Skip to main content

Table 4 Circuit and target lesion (CAS) patency rates at 3,6, and 12 months

From: Treatment of cephalic arch stenosis in dysfunctional arteriovenous fistulas with paclitaxel-coated versus conventional balloon angioplasty

 

All

POBA

PCB

P-value

3-month outcomes

 N

88

63

25

 

 Circuit primary patency, n (%)

63 (71.6)

46 (76.2)

15 (60)

0.209

 Circuit primary assisted patency, n (%)

82 (93.2)

59 (93.7)

23 (92)

1.000

 Target lesion patency, n (%)

67 (76.1)

50 (79.4)

17 (68)

0.395

6-month outcomes

 N

87

62

25

 

 Circuit primary patency, n (%)

36 (41.4)

27 (43.5)

9 (36)

0.685

 Circuit primary assisted patency, n (%)

74 (85.1)

54 (87.1)

20 (80)

0.508

 Target lesion patency, n (%)

45 (51.7)

32 (51.6)

13 (52)

1.000

12-month outcomes

 N

81

59

22

 

 Circuit primary patency, n (%)

15 (18.5)

13 (22)

2 (9.1)

0.219

 Circuit primary assisted patency, n (%)

63 (77.8)

45 (76.3)

18 (81.8)

0.767

 Target lesion patency, n (%)

25 (30.9)

20 (33.9)

5 (22.7)

0.485

  1. POBA Plain Old Balloon Angioplasty, PCB Paclitaxel Coated Balloon